logo
episode-header-image
Oct 2020
29m 53s

Discussing Brain Tumor Research with Dr....

Solving Kids' Cancer
About this episode

WATCH THE VIDEO WEBCAST HERE: https://youtu.be/TwBmCwq3gJc

This week was International Brain Tumor Awareness Week & we're closing out the week with this engaging discussion. TWIPO Host, Dr. Timothy Cripe, met with Dr. Michael Taylor, from SickKids in Toronto, Canada, and Dr. Nabil Ahmed, from Texas Children's Hospital, to discuss their recently published paper on a novel immunotherapy approach for children with metastatic medulloblastoma and ependymoma.

You can read their full paper here: https://pubmed.ncbi.nlm.nih.gov/32341580/

Up next
Jan 2025
DFMO FDA Approval with Dr. Nicole Drezner
In this episode Dr. Timothy Cripe and Dr. Brenda Weigel are joined by FDA's Dr. Nicole Drezner, pediatric oncologist and the Deputy Division Director of the Division of Oncology 2 who led the FDA review and publication on the approval of DFMO. Listen in on the discussion surround ... Show More
35m 23s
Mar 2024
New Focused Ultrasound Study for Progressive Diffuse Midline Glioma
Dr. Luca Szalontay,  Assistant Professor of Pediatrics at Columbia University Medical Center, discusses the work of Columbia's Initiative for Drug Delivery Innovation which is exploring new treatments for pediatric brain tumors utilizing Convection Enhanced Delivery and Focused U ... Show More
24m 31s
Jun 2023
TWiPO #111: A Discussion on Oncofertility/Fertility Preservation with Dr. Seth Rotz
WATCH THE VIDEO WEBCAST HERE: https://youtu.be/ACFprGG10M0 In this episode, our host, Dr. Timothy Cripe from Nationwide Children’s Hospital, is joined by Dr. Seth Rotz - pediatric hematologist/oncologist and the Director of the Fertility Preservation Program at the Cleveland Clin ... Show More
26m 55s
Recommended Episodes
Jul 24
S4 Ep181: The FDA Roundtable on Menopausal Hormone Therapy- And Why I Declined to Participate
I was invited to participate in the FDA roundtable on menopausal hormone therapy. I declined. In this episode, I’m going to tell you why. A brief history of the FDA Why there is a black box warning on all estrogen products Why the black box warning should be removed from all loca ... Show More
25m 57s
Dec 2024
139. Back to Basics - Early HER2 Breast Cancer
Human epidermal growth factor receptor 2 (HER2) is overexpressed in multiple cancers, including breast, gastric, colorectal, and epithelial ovarian cancers. However, this receptor's complexity doesn't stop there. It has multiple subdomains and various responses to drugs, and the ... Show More
24m 31s
Apr 2024
PT500 – Shulgin Farm and the Future of Psychedelic Drug Development, with Paul F. Daley, Ph.D.
In this episode, Joe interviews Paul F. Daley, Ph.D., who worked with Sasha Shulgin in his lab for the last seven years of his life, helping him finish (and co-authoring) "The Shulgin Index, Volume One: Psychedelic Phenethylamines and Related Compounds." He is now the co-founder, ... Show More
36m 1s
Mar 2024
Molding the Future of Wellness: Synthesizing Spirit and Science – Dr. Christina Rahm : 1148
I had the pleasure of talking with Dr. Christina Rahm, who has an inspiring journey from a pharmaceutical executive to an advocate for integrating holistic health solutions with rigorous scientific methods. We dive into the impact of spirituality on wellness, the transformative p ... Show More
1h 16m
Oct 2022
191. #PROSTATE RADIOTHÉRAPIE INTERNE VECTORISÉE PAR 177LU-PSMA-617 DE L’ADÉNOCARCINOME PROSTATIQUE : PRINCIPE ET PERSPECTIVES - DR LÉA TURPIN
Radiothérapie interne vectorisée par 177Lu-PSMA-617 de l’adénocarcinome prostatique : principe et perspectives.Qu’est-ce que la radiothérapie interne vectorisée et quel est son intérêt dans le traitement du cancer prostatique ? Pour quel patient ce traitement est-il actuellement ... Show More
6m 6s
Feb 2025
Can I trust the FDA? (from thalidomide to cough medicine)
#206 Melissa and Jam address a listener's question about the FDA's reliability in approving products. They discuss the intersection of chemistry, government, and society, focusing on FDA's role in regulating food and drugs. The episode includes a deep dive into the historical tha ... Show More
30m 23s
Mar 2023
Accelerating Hope: The Pathway for Cures
When people were dying from AIDS in the 1980s and 90s, Congress found a way to expedite the drug approval process and saved countless lives. Established in 1992, the Accelerated Approval Program allows the FDA to speed approval of drugs for patients with serious and life-threaten ... Show More
23 m
Oct 2023
The FDA: A Spoonful of Safety Makes The Medicine Go Down
On this week's episode of the pod, we are talking about a drug that's been available for decades but is suddenly being pulled from shelves: phenylephrine (something you've probably reached for when you've been congested). We bring on an expert, Dr. Mikkael Sekeres, a Professor of ... Show More
52m 15s
Feb 2025
Type 2 Diabetes Treatments and Major Adverse Cardiovascular Events by Age and Sex, Simvastatin with Rifaximin for Decompensated Liver Cirrhosis, Approved vs Off-label Doxepin Formulation Trends and mo
Editor’s Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief, and Preeti Malani, MD, MSJ, Deputy Editor of JAMA, the Journal of the American Medical Association, for articles published from February 1-7, 2025. 
9m 51s
Sep 2024
Updates in Canine Melanoma with Dr. Fan
Melanoma is a commonly encountered, often metastatic, disease in canine patients. In this episode of Clinician’s Brief Partner Podcast, Dr. Beth invites Dr. Timothy Fan to share advice on the clinical management of melanoma in practice. Dr. Fans offers insights on staging, surgic ... Show More
35m 51s